Multifamily Healing Spaces for Family Resilience in Rwanda (MFHS-CRT)
29 de maio de 2026 atualizado por: Alexandros Lordos, PhD
The Effectiveness of Multi-Family Healing Spaces on Family Resilience and Mental Health Outcomes: A Multi-Site Cluster-Randomized Waitlist-Control Trial in Rwanda
This cluster-randomized waitlist-control trial evaluated Multifamily Healing Spaces (MFHS), a culturally adapted behavioral family intervention for genocide-affected communities in Rwanda.
Community members across five districts were screened through a staged triage process.
Individuals with acute or severe clinical concerns were routed to clinical referral, those with individual mental-health needs were prioritized for Resilience-Oriented Therapy, and families were invited to MFHS when at least one screened family member met criteria for family communication difficulties.
Twenty eligible clusters were randomly selected and then allocated to MFHS or waitlist control.
The baseline cohort included 319 family members aged 12 years or older.
The trial tested whether MFHS improved family resilience, parenting, couple and youth family-system outcomes, and secondary mental health, psychosocial, community, and livelihood outcomes from baseline to immediate post-intervention endline.
Visão geral do estudo
Status
Concluído
Condições
Intervenção / Tratamento
Descrição detalhada
MFHS is a group-based, trauma-informed, family-systems intervention developed for post-genocide Rwanda. It combines psychoeducation, structured dialogue, family communication and problem-solving exercises, parenting and couple-relational work, and youth voice and identity activities. The intervention was delivered in intergenerational, whole-family, parent-only, and youth-only formats. MFHS comprised 18 core 3-hour meeting occasions, with parent-only and youth-only sessions delivered in parallel, plus four planned follow-up sessions where relevant.
Participants were identified through a broader Rwanda societal-healing screening process. Screening was conducted at the individual level, but MFHS invitation occurred at the family level: if any screened individual met the MFHS family-communication criterion, that person's family was invited. The audited screening workbook contained 4,214 adult/community screening records. After referral/triage for severe clinical flags and other staged interventions, 839 screened individuals were staged to MFHS. At the cell level, 56 eligible cells had enough staged MFHS-screened individuals to form a group; those cells contained 794 staged MFHS-screened individuals. Twenty trial clusters were randomly selected from the eligible cells and then allocated to MFHS or waitlist control. The final baseline cohort included 319 family members in 20 clusters: 167 in MFHS clusters and 152 in waitlist-control clusters.
The primary manuscript analysis is a baseline-cohort intention-to-treat analysis. All baseline-assessed participants were retained in their final fielded cluster allocation. Missing endline outcomes for 36 participants were handled through multiple imputation. Effects were estimated with baseline-adjusted cluster-level Analysis of Covariance (ANCOVA) weighted by baseline cluster size, with complete-case and unweighted analyses retained as sensitivity checks.
Tipo de estudo
Intervencional
Inscrição (Real)
319
Estágio
- Não aplicável
Contactos e Locais
Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.
Locais de estudo
-
-
Eastern Province
-
Ngoma, Eastern Province, Ruanda
- Community and Health-Centre Settings, Ngoma District
-
Nyagatare, Eastern Province, Ruanda
- Community and Health-Centre Settings, Nyagatare District
-
-
Northern Province
-
Ruhengeri, Northern Province, Ruanda
- Community and Health-Centre Settings, Musanze District
-
-
Southern Province
-
Nyamagabe, Southern Province, Ruanda
- Community and Health-Centre Settings, Nyamagabe District
-
-
Western Province
-
Nyabihu, Western Province, Ruanda
- Community and Health-Centre Settings, Nyabihu District
-
-
Critérios de participação
Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.
Critérios de elegibilidade
Idades elegíveis para estudo
- Filho
- Adulto
- Adulto mais velho
Aceita Voluntários Saudáveis
Não
Descrição
Inclusion Criteria:
- Member of a family living in or connected to a selected MFHS-eligible cluster/cell in one of the five study districts in Rwanda.
- Aged 12 years or older.
- Family invited because at least one screened family member met the staged MFHS criterion for family communication difficulties after higher-priority clinical and individual mental-health triage.
- Able and willing to participate in baseline assessment and, if allocated to MFHS, family/group sessions.
- Written informed consent, assent, and/or caregiver permission obtained according to age and local ethics requirements.
Exclusion Criteria:
- Individuals with suicidality, psychosis, or severe substance-use flags were routed for clinical interview or hospital referral rather than MFHS as first-line allocation.
- Individuals meeting higher-priority individual mental-health criteria were routed to Resilience-Oriented Therapy before the MFHS screening stage.
- Individuals or families unable to provide consent/assent or safely participate in group family sessions were not enrolled.
- Remaining individuals with social-conflict indicators after earlier stages were routed to sociotherapy rather than MFHS.
Plano de estudo
Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Cuidados de suporte
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Multifamily Healing Spaces
Clusters allocated to Multifamily Healing Spaces (MFHS) received the behavioral family intervention during the trial evaluation period.
MFHS was delivered to families in group formats using intergenerational, whole-family, parent-only, and youth-only sessions.
|
MFHS is a culturally adapted, group-based family intervention for genocide-affected communities in Rwanda.
It includes 18 core 3-hour meeting occasions in intergenerational, whole-family, parent-only, and youth-only formats.
Sessions focus on trauma-informed psychoeducation, family communication and problem solving, shared meaning-making, parenting, couple relationships, youth voice, and family and community resilience.
Groups were facilitated by trained facilitators, including a therapist and community volunteer, with facilitator training and supervision.
|
|
Sem intervenção: Waitlist Control
Clusters allocated to waitlist control did not receive MFHS during the baseline-to-endline evaluation period.
Families were invited to receive MFHS after the evaluation period.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change in Family Resilience
Prazo: Baseline to immediate post-intervention endline, up to 5 months
|
Family resilience was measured with the Walsh Family Resilience Questionnaire.
The local version included 32 items forming belief systems, organization patterns, and communication/problem solving subscales.
Subscale scores range from 1 to 5, with higher scores indicating stronger family resilience processes.
|
Baseline to immediate post-intervention endline, up to 5 months
|
|
Change in Parenting Practices
Prazo: Baseline to immediate post-intervention endline, up to 5 months
|
Parenting practices were measured with the Parenting Practices Questionnaire.
The local version included 20 items forming authoritative warmth/involvement, authoritative democratic participation, and authoritarian verbal hostility subscales.
Subscale scores range from 1 to 5, with higher scores indicating more of the named parenting behavior.
|
Baseline to immediate post-intervention endline, up to 5 months
|
|
Change in Parent Couple Functioning
Prazo: Baseline to immediate post-intervention endline, up to 5 months
|
Parent couple functioning was measured with parent-only measures of dyadic adjustment, dyadic happiness, sexual relationship decision-making power, and preference for boys over girls.
Dyadic adjustment domains range from 0 to 3 and dyadic happiness ranges from 1 to 5, with higher scores indicating better couple functioning.
Sexual relationship decision-making power ranges from 1 to 3, with higher scores indicating more respondent decision-making authority.
Preference for boys over girls ranges from 1 to 4, with higher scores indicating stronger preference for boys over girls.
|
Baseline to immediate post-intervention endline, up to 5 months
|
|
Change in Youth Family-System Functioning
Prazo: Baseline to immediate post-intervention endline, up to 5 months
|
Youth family-system functioning was measured with youth-only family enmeshment and personal accountability scores.
Family enmeshment was measured with seven items ranging from 1 to 5, with higher scores indicating greater over-involvement or lower differentiation.
Personal accountability was measured with eight items ranging from 1 to 4, with higher scores indicating greater youth responsibility and accountability.
|
Baseline to immediate post-intervention endline, up to 5 months
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change in Post-Traumatic Stress Symptoms
Prazo: Baseline to immediate post-intervention endline, up to 5 months.
|
Post-traumatic stress symptoms were measured with four genocide-adapted items from the Posttraumatic Stress Disorder Checklist for the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition.
Items were rated from 0 to 4, with higher scores indicating greater post-traumatic stress symptoms.
|
Baseline to immediate post-intervention endline, up to 5 months.
|
|
Change in Borderline Traits
Prazo: Baseline to immediate post-intervention endline, up to 5 months.
|
Borderline traits were measured with the McLean Screening Instrument for Borderline Personality Disorder.
The 10 yes/no items are summed to a total score ranging from 0 to 10, with higher scores indicating more borderline-personality features.
|
Baseline to immediate post-intervention endline, up to 5 months.
|
|
Change in Aggression
Prazo: Baseline to immediate post-intervention endline, up to 5 months.
|
Aggression was measured with physical and verbal aggression items from the Aggression Questionnaire.
Items were averaged to scores ranging from 1 to 5, with higher scores indicating greater aggression.
|
Baseline to immediate post-intervention endline, up to 5 months.
|
|
Change in Forgiveness and Community Relations
Prazo: Baseline to immediate post-intervention endline, up to 5 months.
|
Forgiveness and community relations were measured with forgiveness of others, social cohesion, perceived community threat, and intergenerational harmony scores.
Forgiveness of others used retained items derived from the Heartland Forgiveness Scale and ranges from 1 to 4, with higher scores indicating greater forgiveness.
Social cohesion ranges from 1 to 4, with higher scores indicating greater social cohesion.
Perceived community threat ranges from 1 to 4, with higher scores indicating greater perceived threat.
Intergenerational harmony ranges from 1 to 4, with higher scores indicating stronger intergenerational harmony.
|
Baseline to immediate post-intervention endline, up to 5 months.
|
|
Change in Socioemotional Skills
Prazo: Baseline to immediate post-intervention endline, up to 5 months.
|
Socioemotional skills were measured with locally developed emotional wellbeing, collaboration, and self-management subscales.
Subscale scores range from 1 to 4. In the scoring, higher scores indicate greater socioemotional difficulty, so lower scores indicate improvement.
|
Baseline to immediate post-intervention endline, up to 5 months.
|
|
Change in Livelihood and Household Economic Functioning
Prazo: Baseline to immediate post-intervention endline, up to 5 months.
|
Livelihood and household economic functioning were measured with parent-only economic security, partner economic support, and food-insecurity indicators.
Economic security and partner economic support scores range from 0 to 3, with higher scores indicating greater economic security or partner support.
Short-term Food Security Consumption Coping Strategy Index scores range from 0 to 84 and long-term scores range from 0 to 12, with higher scores indicating worse food insecurity.
|
Baseline to immediate post-intervention endline, up to 5 months.
|
Colaboradores e Investigadores
É aqui que você encontrará pessoas e organizações envolvidas com este estudo.
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Alexandros Lordos, PhD, University of Cyprus
Publicações e links úteis
A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.
Publicações Gerais
- Lordos, A., Interayamahanga, R., Kayitare, F., Dukuzumuremyi, E., Mahoro, M., Mwiza, J., & Mbanda, J. (2026). Establishing multi-stakeholder alliances to promote societal healing and resilience in post-genocide Rwanda. In S. Clarke-Habibi & C. Reimann (Eds.), The Routledge International Handbook of Trauma-Responsive Peacebuilding (pp. 411-424). Routledge. https://doi.org/10.4324/9781003536970-33
- Nikolaou, K., Lordos, A., Rutembesa, E., Ioannou, M., Dukuzumuremyi, E., Christou, G., Meade, A., Karayianni, E., Anastasiou, E., Guest, A., Sezibera, V., Panayiotou, O., Throstur, B., & Kayitare, F. (2025). Multifamily Healing Spaces: Development of a family-based intervention for recovery and resilience in Rwanda. Intervention, 23(1), 52-62. https://doi.org/10.4103/intv.intv_16_24
Datas de registro do estudo
Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.
Datas Principais do Estudo
Início do estudo (Real)
28 de abril de 2023
Conclusão Primária (Real)
15 de setembro de 2023
Conclusão do estudo (Real)
15 de setembro de 2023
Datas de inscrição no estudo
Enviado pela primeira vez
20 de maio de 2026
Enviado pela primeira vez que atendeu aos critérios de CQ
29 de maio de 2026
Primeira postagem (Real)
2 de junho de 2026
Atualizações de registro de estudo
Última Atualização Postada (Real)
2 de junho de 2026
Última atualização enviada que atendeu aos critérios de controle de qualidade
29 de maio de 2026
Última verificação
1 de maio de 2026
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- MFHS-CRT-RWA-2023
- 122/RNEC/2023 (Outro identificador: Rwanda National Research Ethics Committee approval/reference number)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
SIM
Descrição do plano IPD
De-identified participant-level data underlying the manuscript analyses may be shared with qualified researchers on reasonable request to the first author, subject to ethics, data-protection, and partner-organization approvals.
Prazo de Compartilhamento de IPD
Available after publication, with no predetermined end date.
Critérios de acesso de compartilhamento IPD
Researchers must submit a methodologically sound proposal to the first author.
Access will be subject to approval by the study team and any applicable ethics, data-protection, and partner-organization requirements.
Shared data will be de-identified.
Tipo de informação de suporte de compartilhamento de IPD
- PROTOCOLO DE ESTUDO
- SEIVA
- ANALYTIC_CODE
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Não
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Não
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .